Literature DB >> 22025605

The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions.

Weili Zhang1, Amanda L Chancey, Huei-Ping Tzeng, Zhenqing Zhou, Kory J Lavine, Feng Gao, Natarajan Sivasubramanian, Philip M Barger, Douglas L Mann.   

Abstract

BACKGROUND: Transgenic mice with cardiac-restricted overexpression of tumor necrosis factor (MHCsTNF mice) develop progressive myocardial fibrosis, diastolic dysfunction, and adverse cardiac remodeling. Insofar as tumor necrosis factor (TNF) does not directly stimulate fibroblast collagen synthesis, we asked whether TNF-induced fibrosis was mediated indirectly through interactions between mast cells and cardiac fibroblasts. METHODS AND
RESULTS: Cardiac mast cell number increased 2 to 3 fold (P<0.001) in MHCsTNF mice compared with littermate controls. Outcrossing MHCsTNF mice with mast cell-deficient (c-kit(-/-)) mice showed that the 11-fold increase (P<0.001) in collagen volume fraction in MHCsTNF/c-kit(+/-) mice was abrogated in MHCsTNF/c-kit(-/-) mice, and that the leftward shifted left ventricular pressure-volume curve in the MHCsTNF/c-kit(+/-) mice was normalized in the MHCsTNF/c-kit(-/-) hearts. Furthermore, the increase in transforming growth factor β1 and type I transforming growth factor β receptor messenger RNA levels was significantly (P=0.03, P=0.01, respectively) attenuated in MHCsTNF/c-kit(-/-) when compared with MHCsTNF/c-kit(+/-) mice. Coculture of fibroblasts with mast cells resulted in enhanced α-smooth muscle actin expression, increased proliferation and collagen messenger RNA expression, and increased contraction of 3-dimensional collagen gels in MHCsTNF fibroblasts compared with littermate fibroblasts. The effects of mast cells were abrogated by type I transforming growth factor β receptor antagonist NP-40208.
CONCLUSIONS: These results suggest that increased mast cell density with resultant mast cell-cardiac fibroblast cross-talk is required for the development of myocardial fibrosis in inflammatory cardiomyopathy. Cardiac fibroblasts exposed to sustained inflammatory signaling exhibit an increased repertoire of profibrotic phenotypic responses in response to mast cell mediators.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22025605      PMCID: PMC3217207          DOI: 10.1161/CIRCULATIONAHA.111.052399

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  40 in total

Review 1.  Role of transforming growth factor beta in human disease.

Authors:  G C Blobe; W P Schiemann; H F Lodish
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

2.  Effects of mast cell membrane stabilizing agents in a rat lung ischemia-reperfusion model.

Authors:  K M Vural; H Liao; M C Oz; D J Pinsky
Journal:  Ann Thorac Surg       Date:  2000-01       Impact factor: 4.330

3.  Alteration of transforming growth factor-beta1 response involves down-regulation of Smad3 signaling in myofibroblasts from skin fibrosis.

Authors:  P Reisdorf; D A Lawrence; V Sivan; E Klising; M T Martin
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  Tumor necrosis factor-alpha-induced AT1 receptor upregulation enhances angiotensin II-mediated cardiac fibroblast responses that favor fibrosis.

Authors:  JianFeng Peng; Devorah Gurantz; Van Tran; Randy T Cowling; Barry H Greenberg
Journal:  Circ Res       Date:  2002-12-13       Impact factor: 17.367

5.  Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor.

Authors:  N Sivasubramanian; M L Coker; K M Kurrelmeyer; W R MacLellan; F J DeMayo; F G Spinale; D L Mann
Journal:  Circulation       Date:  2001-08-14       Impact factor: 29.690

6.  Cardiac-specific overexpression of tumor necrosis factor-alpha causes oxidative stress and contractile dysfunction in mouse diaphragm.

Authors:  X Li; M R Moody; D Engel; S Walker; F J Clubb; N Sivasubramanian; D L Mann; M B Reid
Journal:  Circulation       Date:  2000-10-03       Impact factor: 29.690

7.  Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro.

Authors:  D A Siwik; D L Chang; W S Colucci
Journal:  Circ Res       Date:  2000-06-23       Impact factor: 17.367

8.  Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart.

Authors:  Scott P Levick; Jennifer L McLarty; David B Murray; Rebecca M Freeman; Wayne E Carver; Gregory L Brower
Journal:  Hypertension       Date:  2009-04-27       Impact factor: 10.190

9.  Regulation of cardiac fibroblast cellular function by leukemia inhibitory factor.

Authors:  Feng Wang; JoAnn Trial; Abhinav Diwan; Feng Gao; Holly Birdsall; Mark Entman; Peter Hornsby; Natarajan Sivasubramaniam; Douglas Mann
Journal:  J Mol Cell Cardiol       Date:  2002-10       Impact factor: 5.000

10.  Evidence for a role of mast cells in the evolution to congestive heart failure.

Authors:  Masatake Hara; Koh Ono; Myung-Woo Hwang; Atsushi Iwasaki; Masaharu Okada; Kazuki Nakatani; Shigetake Sasayama; Akira Matsumori
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

View more
  45 in total

1.  Mechanical ventilation augments bleomycin-induced epithelial-mesenchymal transition through the Src pathway.

Authors:  Li-Fu Li; Yung-Yang Liu; Kuo-Chin Kao; Chen-Te Wu; Chih-Hao Chang; Chen-Yiu Hung; Cheng-Ta Yang
Journal:  Lab Invest       Date:  2014-06-23       Impact factor: 5.662

Review 2.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

Review 3.  Innate immunity and the failing heart: the cytokine hypothesis revisited.

Authors:  Douglas L Mann
Journal:  Circ Res       Date:  2015-03-27       Impact factor: 17.367

4.  Mast cell-deficiency protects mice from streptozotocin-induced diabetic cardiomyopathy.

Authors:  Aina He; Wenqian Fang; Kun Zhao; Yajun Wang; Jie Li; Chongzhe Yang; Feriel Benadjaoud; Guo-Ping Shi
Journal:  Transl Res       Date:  2019-01-19       Impact factor: 7.012

Review 5.  Reappraising the role of inflammation in heart failure.

Authors:  Luigi Adamo; Cibele Rocha-Resende; Sumanth D Prabhu; Douglas L Mann
Journal:  Nat Rev Cardiol       Date:  2020-01-22       Impact factor: 32.419

6.  Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB.

Authors:  Suresh Kumar Verma; Prasanna Krishnamurthy; David Barefield; Neha Singh; Rajesh Gupta; Erin Lambers; Melissa Thal; Alexander Mackie; Eneda Hoxha; Veronica Ramirez; Gangjian Qin; Sakthivel Sadayappan; Asish K Ghosh; Raj Kishore
Journal:  Circulation       Date:  2012-06-15       Impact factor: 29.690

7.  Reducing Cardiac Fibrosis: Na/K-ATPase Signaling Complex as a Novel Target.

Authors:  X Fan; J Xie; J Tian
Journal:  Cardiovasc Pharm Open Access       Date:  2017-01-31

8.  The emerging prominence of the cardiac mast cell as a potent mediator of adverse myocardial remodeling.

Authors:  Joseph S Janicki; Gregory L Brower; Scott P Levick
Journal:  Methods Mol Biol       Date:  2015

9.  Effect of dietary fat and sucrose consumption on cardiac fibrosis in mice and rhesus monkeys.

Authors:  Niranjana Natarajan; Ana Vujic; Jishnu Das; Annie C Wang; Krystal K Phu; Spencer H Kiehm; Elisabeth M Ricci-Blair; Anthony Y Zhu; Kelli L Vaughan; Ricki J Colman; Julie A Mattison; Richard T Lee
Journal:  JCI Insight       Date:  2019-09-19

Review 10.  Role of inflammatory cells in fibroblast activation.

Authors:  Justin Hartupee; Douglas L Mann
Journal:  J Mol Cell Cardiol       Date:  2015-11-20       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.